Concepedia

Publication | Open Access

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

78

Citations

29

References

2023

Year

Abstract

HuNb<sub>TROP2-HSA</sub>-MMAE has desirable affinity, internalization efficiency and antitumor activity. It holds significant promise as a potential therapeutic option for the treatment of TROP2-positive pancreatic cancer.

References

YearCitations

Page 1